Back
Corbus Pharmaceuticals Holdings Quote, Financials, Valuation and Earnings
Invest. Do Good. Get Rewarded. Just $0.26/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
45
CRBP
Corbus Pharmaceuticals Holdings
Last Price:
17.45
Seasonality Move:
53.7%
7 Day Trial
ALL ACCESS PASS
$
7
Say this - unlock as much as $1,250 every Friday
Click here for full details.Corbus Pharmaceuticals Holdings Price Quote
$17.45
-0.02 (4.3%)
(Updated: November 23, 2024 at 5:30 AM ET)
Corbus Pharmaceuticals Holdings Key Stats
Sell
45
Corbus Pharmaceuticals Holdings (CRBP)
is a Sell
Day range:
$16.50 - $17.75
52-week range:
$4.00 - $61.90
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
101.55
P/B ratio:
1.41%
Volume:
177.6K
Avg. volume:
354.3K
1-year change:
306.28%
Market cap:
$212.8M
Revenue:
$0
EPS:
$-4.67
How Much Does Corbus Pharmaceuticals Holdings Make?
Data Unavailable
Is Corbus Pharmaceuticals Holdings Growing As A Company?
Data Unavailable
Corbus Pharmaceuticals Holdings Stock Price Performance
-
Did Corbus Pharmaceuticals Holdings Stock Go Up Last Month?
Corbus Pharmaceuticals Holdings share price went up by 0.06% last month -
Did CRBP's Share Price Rise Over The Last Year?
CRBP share price rose by 306.28% over the past 1 year
What Is Corbus Pharmaceuticals Holdings 52-Week High & Low?
-
What Is Corbus Pharmaceuticals Holdings’s 52-Week High Share Price?
Corbus Pharmaceuticals Holdings has traded as high as $61.90 over the past 52 weeks -
What Is Corbus Pharmaceuticals Holdings’s 52-Week Low Share Price?
Corbus Pharmaceuticals Holdings has traded as low as $4.00 over the past 52 weeks
Corbus Pharmaceuticals Holdings Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Corbus Pharmaceuticals Holdings?
-
How Much Debt Does Corbus Pharmaceuticals Holdings Have?
Total long term debt quarterly is $0 -
How Much Cash Does Corbus Pharmaceuticals Holdings Have?
Cash and short term investments quarterly total is $159.4M -
What Is Corbus Pharmaceuticals Holdings’s Book Value Per Share?
Book value per share is 12.36
Is Corbus Pharmaceuticals Holdings Cash Flow Positive?
-
What Is CRBP Cash Flow From Operations?
Cash flow from operations (TTM) is -$36.9M -
What Is Corbus Pharmaceuticals Holdings’s Cash Flow From Financing?
Cash flow from financing (TTM) is $164.7M -
What Is Corbus Pharmaceuticals Holdings’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$119.7M
Corbus Pharmaceuticals Holdings Return On Invested Capital
Data Unavailable
Corbus Pharmaceuticals Holdings Earnings Date & Stock Price
-
What Is Corbus Pharmaceuticals Holdings's Stock Price Today?
A single share of CRBP can be purchased today for 17.47 -
What Is Corbus Pharmaceuticals Holdings’s Stock Symbol?
Corbus Pharmaceuticals Holdings trades on the nasdaq under the ticker symbol: CRBP -
When Is Corbus Pharmaceuticals Holdings’s Next Earnings Date?
The next quarterly earnings date for Corbus Pharmaceuticals Holdings is scheduled on March 12, 2025 -
When Is CRBP's next ex-dividend date?
Corbus Pharmaceuticals Holdings's next ex-dividend date is May 30, 2020 -
How To Buy Corbus Pharmaceuticals Holdings Stock?
You can buy Corbus Pharmaceuticals Holdings shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Corbus Pharmaceuticals Holdings Competitors
-
Who Are Corbus Pharmaceuticals Holdings's Competitors?
Below is a list of companies who compete with Corbus Pharmaceuticals Holdings or are related in some way:
Corbus Pharmaceuticals Holdings Dividend Yield
-
What Is CRBP Dividend Yield?
Corbus Pharmaceuticals Holdings’s dividend yield currently is 0% -
What Is Corbus Pharmaceuticals Holdings’s Payout Ratio?
Corbus Pharmaceuticals Holdings’s payout ratio is 0% -
When Did Corbus Pharmaceuticals Holdings Last Pay A Dividend?
The latest dividend pay date is November 23, 2024 -
What Is Corbus Pharmaceuticals Holdings’s Dividend Per Share?
Corbus Pharmaceuticals Holdings pays a dividend of $0.00 per share
Corbus Pharmaceuticals Holdings Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | -20.74% |
| Revenue: | 0% | 0% |
Analyst Recommendations
| Buy Recommendations: | 6 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 59.50 |
| Upside from Last Price: | 240.58% |